[CLDX] YoY Annual Result on 31-Dec-2014 [#FY]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
24-Feb-2015
Financial Year
2014
Quarter
31-Dec-2014 [#FY]
Profit Trend
YoY- -44.79%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Annual Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 12,743 6,786 5,480 3,586 4,111 11,202 9,265 5.45%
PBT -117,313 -128,530 -127,197 -118,080 -81,550 -59,123 -44,799 17.38%
Tax -24,282 -8,772 -2,344 -4,350 -819 -530 -446 94.56%
NP -93,031 -128,530 -127,197 -118,080 -81,550 -59,123 -44,799 12.93%
Tax Rate - - - - - - - -
Total Cost 105,774 135,316 132,677 121,666 85,661 70,325 54,064 11.82%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin -730.06 -1,894.05 -2,321.11 -3,292.81 -1,983.70 -527.79 -483.53 7.10%
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
EPS -10.86 -18.99 -19.66 -19.81 -15.33 -15.37 -17.01 -7.19%
EPS Diluted -10.86 -18.99 -19.66 -19.81 -15.33 -15.37 -17.01 -7.19%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.